Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer

被引:0
|
作者
Jan, H. [1 ]
Balint, T. [1 ]
Boelke, E. [1 ]
Noel, D. Freddy [1 ]
Wilfried, B. [1 ]
Kai, K. [2 ]
Christiane, M. [1 ]
机构
[1] Univ Hosp Dusseldorf, Radiat Oncol, Dusseldorf, Germany
[2] Johns Hopkins Univ, Sch Med, Dept Oncol, Div Biostat & Bioinformat, Baltimore, MD 21205 USA
关键词
D O I
10.1016/S0167-8140(19)31137-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO-0717
引用
收藏
页码:S368 / S369
页数:2
相关论文
共 50 条
  • [1] Hyperfractionated radiotherapy versus hyperfractionated radiotherapy and concomitant chemotherapy in locally advanced head and neck cancer
    Kasibhatla, M.
    Prosnitz, L. R.
    Fisher, S. R.
    Scher, R. L.
    Clough, R.
    Brizel, D. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S11 - S12
  • [2] Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer-a meta-analysis
    Haussmann, Jan
    Tamaskovics, Balint
    Boelke, Edwin
    Djiepmo-Njanang, Freddy-Joel
    Kammers, Kai
    Corradini, Stefanie
    Hautmann, Matthias
    Ghadjar, Pirus
    Maas, Kitti
    Schuler, Patrick J.
    Hoffmann, Thomas K.
    Lammering, Guido
    Budach, Wilfried
    Matuschek, Christiane
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (12) : 1041 - 1049
  • [3] Induction chemotherapy followed by hyperfractionated radiotherapy with concurrent chemotherapy for locally advanced head and neck cancer
    Karasawa, K
    Shinoda, H
    Katsui, K
    Seki, K
    Kohno, M
    Hanyu, N
    Nasu, S
    Muramatsu, H
    Maebayashi, K
    Mitsuhashi, N
    Yoshihara, T
    [J]. ANTICANCER RESEARCH, 2003, 23 (6D) : 5031 - 5036
  • [4] Hyperfractionated radiotherapy with concurrent docetaxel for advanced head and neck cancer
    Karasawa, K.
    Ito, K.
    Takada, T.
    Matsumoto, F.
    Haruyama, T.
    Ito, S.
    Ikeda, K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S450 - S451
  • [5] Hyperfractionated radiation combined with chemotherapy in advanced head and neck cancer
    Gottardo, C
    Landmann, C
    Lohri, A
    Wolfensberger, M
    [J]. CURRENT PROBLEMS IN OTOLARYNGOLOGY 21, 1998, 21 : 203 - 212
  • [6] Moderate dose hyperfractionated radiotherapy and concurrent chemotherapy for head and neck cancer
    Aref, A.
    Chuba, P.
    Samani, K.
    Toole, A.
    Leonard, R.
    Salama, D.
    Denton, L.
    Patel, D.
    Agnone, E.
    Browne, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S344 - S345
  • [7] Concurrent weekly docetaxel and hyperfractionated radiotherapy for advanced head and neck cancer
    Matsumoto, Fumihiko
    Karasawa, Kumiko
    Itoh, Shin
    Toda, Megumi
    Haruyama, Takuo
    Furukawa, Masayuki
    Ikeda, Katsuhisa
    [J]. ANTICANCER RESEARCH, 2006, 26 (5B) : 3781 - 3786
  • [8] Improved results with accelerated hyperfractionated radiotherapy of advanced head and neck cancer
    Leborgne, F
    Zubizarreta, E
    Fowler, J
    Ortega, B
    Mezzera, J
    Deus, JL
    Leborgne, JH
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2000, 90 (02) : 80 - 91
  • [9] Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer
    Glicksman, AS
    Wanebo, HJ
    Slotman, G
    Liu, L
    Landmann, C
    Clark, J
    Zhu, TC
    Lohri, A
    Probst, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (03): : 721 - 729
  • [10] Accelerated hyperfractionated radiotherapy and concurrent protracted venous infusion chemotherapy in locally advanced head and neck cancer
    Arcangeli, G
    Saracino, B
    Danesi, DT
    de Campora, E
    Giovinazzo, G
    Cognetti, F
    Carlini, P
    Arcangeli, S
    Mecozzi, A
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (05): : 431 - 437